Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Eli Lilly & Co (LLY)  
$770.00 1.12 (0.15%) as of 4:30 Fri 5/17


Download
   
Exchange: New York Stock Exchange
Security Type: Common
Shares Out: 956,580,000
Market Cap: 736.57(B)
Last Volume: 1,669,189 Avg Vol: 3,285,540
52 Week Range: $423.21 - $792.28
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Drug Manufacturers - Major

Member Indexes:
    S&P COMPOSITE 1500     NYSE COMPOSITE
    S&P 500

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  720
Guru Rank Value     : 1.4
Guru Occurances    : 2

 

            6 Months   1 Year   2 Year  
 
Company Profile   Eli Lilly and Company discovers, develops, manufactures, and markets products in a single business segment: human pharmaceutical products. Co.'s products include: diabetes products, oncology products, immunology products, neuroscience products, and other therapies. Co.'s diabetes products include: Baqsimi®, Basaglar®, Humalog®, Humulin®, Jardiance®, Lyumjev®, Trajenta®, and Trulicity®. Co.'s oncology products include: Alimta®, Cyramza®, Erbitux®, Retevmo®, Tyvyt®, and Verzenio®. Co.'s immunology products include: Olumiant® and Taltz®. Co.'s neuroscience products include: Cymbalta®, Emgality®, Reyvow®, and Zyprexa®. Co.'s other therapies include: Bamlanivimab, Cialis®, and Forteo®.


 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 656
Total Buy Value $0 $0 $0 $199,549
Total People Bought 0 0 0 1
Total Buy Transactions 0 0 0 1
Total Shares Sold 750 870,750 2,710,260 6,110,274
Total Sell Value $565,200 $608,250,580 $2,147,483,647 $2,147,483,647
Total People Sold 1 2 5 6
Total Sell Transactions 1 13 42 86
End Date 2024-02-18 2023-11-17 2023-05-19 2022-05-19

   
Records found: 3297
  Page 20 of 132  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Alvarez Ralph Director   –       •      –    2021-03-15 4 A $189.16 $10,971 D/D 58 49,459     -
   Tai Jackson P Director   –       •      –    2021-03-15 4 A $189.16 $1,892 D/D 10 59,819     -
   Johnson Kimberly H Director   –       •      –    2021-03-15 4 A $189.16 $9,647 D/D 51 51     -
   Lilly Endowment Inc 10% Owner   –       –       •   2021-03-09 4 S $209.12 $12,579,032 D/D (59,959) 110,302,100 -14%     
   Lilly Endowment Inc 10% Owner   –       –       •   2021-03-08 4 S $209.29 $26,271,092 D/D (125,284) 110,362,059 -12%     
   Hakim Anat SVP, GC & Secretary   •       –      –    2021-03-01 4 D $204.89 $715,681 D/D (3,493) 4,435     -
   Hakim Anat SVP, GC & Secretary   •       –      –    2021-03-01 4 OE $0.00 $0 D/D 7,928 7,928     -
   Tai Jackson P Director   –       •      –    2021-02-16 4 A $205.76 $2,058 D/D 10 59,750     -
   Alvarez Ralph Director   –       •      –    2021-02-16 4 A $207.76 $11,011 D/D 53 49,198     -
   Ashkenazi Anat SVP & CFOOfficer   •       –      –    2021-02-09 3 IO $0.00 $0 I/I 0 253 10%     
   Ashkenazi Anat SVP & CFOOfficer   •       –      –    2021-02-09 3 IO $0.00 $0 D/D 0 17,700 10%     
   Zakrowski Donald A Chief Accounting Officer   •       –      –    2021-02-08 4 A $205.77 $873,905 D/D 4,247 8,987     -
   Yuffa Ilya SVP and Pres, Lilly Bio-Meds   •       –      –    2021-02-08 4 A $205.77 $727,603 D/D 3,536 10,349     -
   Barnes Melissa S Chief Eth/Cmpl Ofcr & SVP, ERM   •       –      –    2021-02-08 4 A $205.77 $1,974,157 D/D 9,594 34,616     -
   Smiley Joshua L Former Officer   –       –      –    2021-02-08 4 A $205.77 $5,228,410 D/D 25,409 77,659     -
   White Anne E. SVP & Pres-Lilly Oncology   •       –      –    2021-02-08 4 A $205.77 $970,823 D/D 4,718 33,840     -
   Pusey Leigh Ann SVP, Corp. Affairs & Comm.   •       –      –    2021-02-08 4 A $205.77 $2,220,464 D/D 10,791 18,529     -
   Ricks David A President & CEO   •       •      –    2021-02-08 4 A $205.77 $26,820,679 D/D 130,343 440,244     -
   Mason Michael B Sr. VP & Pres., Lilly Diabetes   •       –      –    2021-02-08 4 A $205.77 $1,306,640 D/D 6,350 24,894     -
   Oneill Myles SVP & Pres., Mfg. Operations   •       –      –    2021-02-08 4 A $205.77 $4,331,870 D/D 21,052 72,533     -
   Zulueta Alfonso G SVP & President, Lilly Intl   •       –      –    2021-02-08 4 A $205.77 $5,974,943 D/D 29,037 56,947     -
   Skovronsky Daniel SVP, CSO, and Pres. LRL   •       –      –    2021-02-08 4 A $205.77 $3,811,066 D/D 18,521 115,680     -
   Shah Aarti S. SVP & CIDO   •       –      –    2021-02-08 4 A $205.77 $2,270,260 D/D 11,033 31,622     -
   Norton Johna Senior VP, Global Quality   •       –      –    2021-02-08 4 A $205.77 $1,242,851 D/D 6,040 25,464     -
   Fry Stephen F SVP, HR & Diversity   •       –      –    2021-02-08 4 A $205.77 $5,377,387 D/D 26,133 134,676     -
  3297 Records found
  Previous  20  21  22  23  24  25  26  27  28  29  Next   
  Page 20 of 132
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us